Summary
Serena Williams appeared in a Super Bowl ad for Ro, a telehealth company, promoting GLP-1 weight loss drugs. The ad faced criticism online, with some saying it was inappropriate for a former athlete to advertise weight loss products. Williams stated the drugs helped her lose weight and improve her health.
Key Facts
- Serena Williams featured in a Super Bowl ad for Ro, promoting weight loss drugs called GLP-1.
- Williams claimed the drug helped her lose 34 pounds and improve other health markers.
- Critics on social media expressed concern about promoting weight loss drugs during a widely-watched event.
- GLP-1 drugs are used for weight loss and type-2 diabetes treatment.
- About 12% of Americans have tried GLP-1 drugs for weight loss.
- Ro, the telehealth company, offers medical services and began selling GLP-1 drugs as pills and injections.
- Williams' husband is an investor in Ro and serves on its board.
- Ro states its medications have helped many patients with both weight loss and health improvements.
